Összefoglaló. Különböző tényezők következtében az új és újra felbukkanó fertőző betegségek megjelenésére a 21. században egyre nagyobb az esély, ezzel párhuzamosan a pandémiák kialakulása is nagyobb valószínűségű. A 2019-ben felbukkant COVID–19-járvány azt is közvetíti számunkra, hogy egyes új és újra jelentkező fertőző betegségek – az eredményes intézkedések elmaradása, késlekedése esetén – gyorsan terjedhetnek. A fertőző betegségek elleni harc egyik fő eszköze a védőoltás segítségével történő immunizáció. A jelen tanulmány célja bemutatni a védőoltások előnyeit, fókuszba helyezve az elöregedő társadalomban az élethosszan tartó immunizációs stratégiának a személyes egészségre ható, közegészségügyi, gazdasági, valamint társadalmi érdekeit. Az oltás előnyeinek minél nagyobb fokú kihasználásához egy élethosszan tartó immunizációs stratégia felállítása javasolható, amelynek aspektusait és gyakorlatba ültetésének lehetséges lépéseit foglaltuk össze közleményünkben. Orv Hetil. 2022; 163(14): 535–543.
Summary. Due to various factors, the chances of infectious disease emergence or re-emergence have increased in the 21st century, thus, the likelihood of new emerging pandemics has also increased. The COVID–19 pandemic, which appeared in 2019, has highlighted that certain new and re-emerging infectious diseases – in the case of lack or delay in effective measures – can spread very rapidly. The main tool for the fight against infectious diseases is immunization through vaccination. While focusing on the personal health, public health, economic and societal benefits of a lifelong immunization strategy, especially in light of the aging society, the goal of this paper is to present the benefits of vaccines. In order to increase the added value of vaccinations it is recommended to create a lifelong immunization strategy. Our paper summarizes the relevant aspects of such a strategy, highlighting potential practical steps towards implementation. Orv Hetil. 2022; 163(14): 535–543.
Bonanni P, Sacco C, Donato R, et al. Lifelong vaccination as a key disease-prevention strategy. Clin Microbiol Infect. 2014; 20 (Suppl 5): 32–36.
Kuehn B. Poliovirus type 3 is eradicated. JAMA 2019; 322: 2276.
World Health Organization (WHO). COVID-19 vaccines and vaccination. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/covid-19-vaccines-and-vaccination [accessed: March 1, 2021].
Thomas MB. Epidemics on the move: climate change and infectious disease. PLoS Biol. 2020; 18: e3001013.
Huynen MM, Martens P, Hilderink HB. The health impacts of globalization: a conceptual framework. Global Health 2005; 1: 14.
World Health Organization (WHO). The best time to prevent the next pandemic is now: countries join voices for better emergency preparedness. 1 October 2020. Available from: https://www.who.int/news/item/01-10-2020-the-best-time-to-prevent-the-next-pandemic-is-now-countries-join-voices-for-better-emergency-preparedness [accessed: October 30, 2021].
World Health Organization (WHO). Director-General’s closing remarks at the World Health Assembly – 31 May 2021. Available from: https://www.who.int/director-general/speeches/detail/director-general-s-closing-remarks-at-the-world-health-assembly---31-may-2021 [accessed: October 28, 2021].
Global Coalition on Aging. Life-course immunization. A driver of healthy aging. Available from: https://globalcoalitiononaging.com/wp-content/uploads/2018/07/life-course-immunization_gcoa-for-web-1.pdf [accessed: December 1, 2020].
Ginsburg AS, Klugman KP. Vaccination to reduce antimicrobial resistance. Lancet Glob Health 2017; 5: e1176–e1177.
Partnership for prevention. Preventive care: a national profile on use, disparities, and health benefits. Available from: https://www.rwjf.org/en/library/research/2007/08/preventive-care-national-profile-on-use.html [accessed: December 1, 2020].
Organisation for Economic Co-operation and Development (OECD). Child vaccination rates, 2018. Available from: https://data.oecd.org/healthcare/child-vaccination-rates.htm [accessed: December 1, 2020].
OECD/European Observatory on Health Systems and Policies. Hungary: Country Health Profile 2019, State of Health in the EU, OECD Publishing, Paris/European Observatory on Health Systems and Policies, Brussels. Available from: https://www.euro.who.int/__data/assets/pdf_file/0007/419461/Country-Health-Profile-2019-Hungary.pdf [accessed: December 1, 2020].
Eurostat. 41% of elderly people vaccinated against influenza. Available from: https://ec.europa.eu/eurostat/web/products-eurostat-news/-/DDN-20200915-1 [accessed: December 1, 2020].
Jorgensen P, Mereckiene J, Cotter S, et al. How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine 2018; 36: 442–452.
Mészáros J, Kásler M, Varga M. Budget of 2019 – LXXI. Pension Insurance Fund. [2019. évi költségvetés – LXXI. Nyugdíjbiztosítási Alap.] Available from: https://www.parlament.hu/irom41/00503/adatok/fejezetek/71.pdf [accessed: December 1, 2020]. [Hungarian]
Hungarian Central Statistical Office. Number of employees by age groups, by sex (thousand persons). [Központi Statisztikai Hivatal (KSH). A foglalkoztatottak száma korcsoportok szerint, nemenként (ezer fő).] Available from: https://www.ksh.hu/stadat_files/mun/hu/mun0007.html [accessed: October 12, 2021]. [Hungarian]
European Commission. Informal care in Europe. Exploring formalisation, availability and quality. Available from: https://op.europa.eu/en/publication-detail/-/publication/96d27995-6dee-11e8-9483-01aa75ed71a1 [accessed: September 10, 2020].
Hungarian Central Statistical Office. Household work, voluntary work, invisible work, I. Measurement and analysis of household and voluntary work I. [Központi Statisztikai Hivatal (KSH). Háztartási munka, önkéntes munka, láthatatlan munka, I. Háztartási és önkéntes munka mérése, elemzése I.] Available from: https://www.ksh.hu/docs/hun/xftp/idoszaki/pdf/lathatatlan_munka_1.pdf [accessed: September 10, 2020]. [Hungarian]
Michel JP, Gusmano M, Blank PR, et al. Vaccination and healthy ageing: how to make life-course vaccination a successful public health strategy. Eur Geriatr Med. 2010; 1: 155–165.
National Center for Public Health. Methodological letter from the National Public Health Center on the 2021 vaccinations. [A Nemzeti Népegészségügyi Központ módszertani levele a 2021. évi védőoltásokról.] Available from: https://www.antsz.hu/data/cms100122/VML_2021_NNK.pdf [accessed: October 12, 2021]. [Hungarian]
Schmid P, Rauber D, Betsch C, et al. Barriers of influenza vaccination intention and behavior – a systematic review of influenza vaccine hesitancy, 2005–2016. PLoS ONE 2017; 2: e0170550.
IPSOS. Three in four adults globally say they would get a vaccine for COVID-19. 31 August 2020. Available from: https://www.ipsos.com/en-us/news-polls/WEF-covid-vaccine-global [accessed: December 1, 2020].
Wilson SL, Wiysonge C. Social media and vaccine hesitancy. BMJ Glob Health 2020; 5: e004206.
Gaál P, Joó T, Palicz T, et al. Innovation in data science to address the environmental challenges of health systems: the significance and opportunities of the analysis of big routine datasets in pandemic management. [Adattudományi innováció az egészségügy környezeti kihívásainak kezelésében: a nagy adatállományok hasznosításának jelentősége és lehetőségei a járványkezelésben.] Scientia et Securitas 2021; 2: 2–11. [Hungarian]
Jarrett C, Wilson R, O’Leary M, et al. Strategies for addressing vaccine hesitancy – a systematic review. Vaccine 2015; 33: 4180–4190.
Hoyt K. Medical countermeasures and security. In: Rushton S, Youde J. (eds.) Routledge Handbook of Global Health Security. Routledge, London, 2014, pp. 11.
Purcell D. 3 mRNA vaccines researchers are working on (that aren’t COVID). 27 Apr, 2021. Available from: https://www.weforum.org/agenda/2021/04/mrna-vaccines-research-development-flu-cancer/ [accessed: June 1, 2021].
Vaccines Europe. European Flu Day Webinar. Available from: https://www.vaccineseurope.eu/news/articles/the-first-annual-eu-flu-day [accessed: March 1, 2021].
Centers for Disease Control and Prevention (CDC). COVID-19 vaccination program. Interim playbook for jurisdiction operations – October 29, 2020. Available from: https://www.cdc.gov/vaccines/imz-managers/downloads/COVID-19-Vaccination-Program-Interim_Playbook.pdf [accessed: December 1, 2020].
[30 ] Hungarian Association of Pharmacy and Association of Innovative Pharmaceutical Manufacturers. The question of the potential option regarding pharmacological vaccination based on the results of the domestic survey, in order to improve the public health status of Hungary. [Magyar Gyógyszerészi Kamara (MGYK) és Innovatív Gyógyszergyártók Egyesülete (IGYE) (n. d) A gyógyszerészi oltás lehetőségének kérdése a lakossági hozzáférés tükrében, hazánk népegészségügyi státuszának javítására.] [Hungarian]
Frost L, Wissenbach I. Airlines scramble to prepare for ultra-cold COVID-19 vaccine distribution. Reuters, 2020. Available from: https://www.reuters.com/article/us-health-coronavirus-airlines-freight-a/airlines-scramble-to-prepare-for-ultra-cold-covid-19-vaccine-distribution-idUSKBN27Y0NN [accessed: December 1, 2020].
Palicz T, Bencsik B, Szócska M. Cyber security in the time of the coronavirus. National security aspects of COVID–19. [Kiberbiztonság a koronavírus idején. A COVID–19 nemzetbiztonsági aspektusai.] Scientia et Securitas 2021; 2: 78–87. [Hungarian]
Ministry of Human Resources. „Strategy For Healthy Hungary 2021–2027.” [Emberi Erőforrások Minisztériuma. „Egészséges Magyarország 2021−2027” Egészségügyi Ágazati Stratégia.] Emberi Erőforrások Minisztériuma, Budapest, 2021. január. Available from: https://mok.hu/transzparencia/allasfoglalasok-szakmai-velemenyek [accessed: June 1, 2021]. [Hungarian]